Alpha‐synuclein co‐pathology in a real‐world early Alzheimer's disease cohort

20260 citationsJournal Articlehybrid Open Access

Authors

Tamara Shiner · Tel Aviv University

Talya Nathan · Tel Aviv Sourasky Medical Center

M. Levy · Tel Aviv Sourasky Medical Center

Aya Bar David · Tel Aviv Sourasky Medical Center

Nurit Omer · Tel Aviv Sourasky Medical Center

Anan Abu Awad · Tel Aviv Sourasky Medical Center

Elissa L. Ash

Abstract

αS-SAA positivity is common in early AD and associated with olfactory dysfunction. Longitudinal follow-up is required to test if assay status predicts response to ATTs.

Topics & Keywords

Olfactory and Sensory Function Studies Neurological Disease Mechanisms and Treatments Dementia and Cognitive Impairment Research

Publication Details

Published in: Alzheimer s & Dementia

Volume 22, Issue 3, pp. e71240-e71240

DOI: 10.1002/alz.71240

Field-Weighted Citation Impact: 0.00

Command Palette

Alpha‐synuclein co‐pathology in a real‐world early Alzheimer's disease cohort

Authors

Abstract

Topics & Keywords

Publication Details